135 related articles for article (PubMed ID: 14602710)
1. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease.
Hernández F; Pérez M; Lucas JJ; Mata AM; Bhat R; Avila J
J Biol Chem; 2004 Jan; 279(5):3801-6. PubMed ID: 14602710
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines.
Lee CW; Lau KF; Miller CC; Shaw PC
Neuroreport; 2003 Feb; 14(2):257-60. PubMed ID: 12598741
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
Zhou J; Yu Q; Zou T
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic implications of glycogen synthase kinase-3β in Alzheimer's disease: a novel therapeutic target.
Mandlik DS; Mandlik SK; S A
Int J Neurosci; 2024 Jun; 134(6):603-619. PubMed ID: 36178363
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.
Ikeda M; Shoji M; Kawarai T; Kawarabayashi T; Matsubara E; Murakami T; Sasaki A; Tomidokoro Y; Ikarashi Y; Kuribara H; Ishiguro K; Hasegawa M; Yen SH; Chishti MA; Harigaya Y; Abe K; Okamoto K; St George-Hyslop P; Westaway D
Am J Pathol; 2005 Feb; 166(2):521-31. PubMed ID: 15681835
[TBL] [Abstract][Full Text] [Related]
9. Cdc42GAP deficiency contributes to the Alzheimer's disease phenotype.
Zhu M; Xiao B; Xue T; Qin S; Ding J; Wu Y; Tang Q; Huang M; Zhao N; Ye Y; Zhang Y; Zhang B; Li J; Guo F; Jiang Y; Zhang L; Zhang L
Brain; 2023 Oct; 146(10):4350-4365. PubMed ID: 37254741
[TBL] [Abstract][Full Text] [Related]
10. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.
Smith PY; Hernandez-Rapp J; Jolivette F; Lecours C; Bisht K; Goupil C; Dorval V; Parsi S; Morin F; Planel E; Bennett DA; Fernandez-Gomez FJ; Sergeant N; Buée L; Tremblay MÈ; Calon F; Hébert SS
Hum Mol Genet; 2015 Dec; 24(23):6721-35. PubMed ID: 26362250
[TBL] [Abstract][Full Text] [Related]
11. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.
Lester E; Ooi FK; Bakkar N; Ayers J; Woerman AL; Wheeler J; Bowser R; Carlson GA; Prusiner SB; Parker R
Neuron; 2021 May; 109(10):1675-1691.e9. PubMed ID: 33848474
[TBL] [Abstract][Full Text] [Related]
12. 14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1.
Chun J; Kwon T; Lee EJ; Kim CH; Han YS; Hong SK; Hyun S; Kang SS
Mol Cells; 2004 Dec; 18(3):360-8. PubMed ID: 15650334
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3: a key regulator of cellular fate.
Forde JE; Dale TC
Cell Mol Life Sci; 2007 Aug; 64(15):1930-44. PubMed ID: 17530463
[TBL] [Abstract][Full Text] [Related]
14. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases.
Wang C; Cui Y; Xu T; Zhou Y; Yang R; Wang T
Biochem Pharmacol; 2023 Dec; 218():115923. PubMed ID: 37981175
[TBL] [Abstract][Full Text] [Related]
15. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis.
Xiao R; Sun Y; Ding JH; Lin S; Rose DW; Rosenfeld MG; Fu XD; Li X
Mol Cell Biol; 2007 Aug; 27(15):5393-402. PubMed ID: 17526736
[TBL] [Abstract][Full Text] [Related]
16. Identification of two short peptide motifs from serine/arginine-rich protein ribonucleic acid recognition motif-1 domain acting as splicing regulators.
Jiang T; Wang L; Tang L; Zeb A; Hou Y
PeerJ; 2023; 11():e16103. PubMed ID: 37744237
[TBL] [Abstract][Full Text] [Related]
17. Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure.
Pena E; San Martin-Salamanca R; El Alam S; Flores K; Arriaza K
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255962
[TBL] [Abstract][Full Text] [Related]
18. Spag16, an axonemal central apparatus gene, encodes a male germ cell nuclear speckle protein that regulates SPAG16 mRNA expression.
Nagarkatti-Gude DR; Jaimez R; Henderson SC; Teves ME; Zhang Z; Strauss JF
PLoS One; 2011; 6(5):e20625. PubMed ID: 21655194
[TBL] [Abstract][Full Text] [Related]
19. [Tau Protein Induces Aberrant Alternative Splicing Changes in PS19 Transgenic Mice].
Tian X; Chen C; Wang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):874-883. PubMed ID: 37866941
[TBL] [Abstract][Full Text] [Related]
20. Changes in brain MicroRNAs contribute to cholinergic stress reactions.
Meerson A; Cacheaux L; Goosens KA; Sapolsky RM; Soreq H; Kaufer D
J Mol Neurosci; 2010 Jan; 40(1-2):47-55. PubMed ID: 19711202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
